Experienced in Heart Attack

Christoph Stellbrink

Teutoburger Str. 50, 
Bielefeld, NW, DE 
Experienced in Heart Attack
Teutoburger Str. 50, 
Bielefeld, NW, DE 
OverviewLocationsClinical Research

Overview

Christoph Stellbrink practices in Bielefeld, Germany. Mr. Stellbrink is rated as an Experienced expert by MediFind in the treatment of Heart Attack. His top areas of expertise are Central Sleep Apnea, Hypertrophic Cardiomyopathy (HCM), Heart Block, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Heart Attack.

Gender
Male

Locations

Teutoburger Str. 50, Bielefeld, NW 33604, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Enrollment Status: Completed
Publish Date: June 29, 2025
View 1 Less Clinical Trial

92 Total Publications

Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
Journal: Cardiovascular research
Published: August 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stellbrink's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile